In June 2019, President Trump signed the Advancing American Kidney Health Initiative (AAKHI) executive order, which aims to reduce the number of chronic kidney disease (CKD) patients who progress to… Read more
At DaVita, creating an exceptional, caring experience for our dialysis patients is our top priority. For patients living with chronic kidney conditions, receiving consistent, quality care can make a world… Read more
On May 20, 1747, James Lind, a surgeon aboard a British Royal Navy ship, conducted what is widely believed to be the first clinical trial when he examined the effect… Read more
Today, it seems that many conversations we have with loved ones are centered around how COVID-19 is affecting our daily lives. However, for patients on dialysis and many other vulnerable populations,… Read more
Over the past few years, we have seen a major increase in the consolidation of smaller central IRBs into larger organizations. Where there used to be a couple dozen independent… Read more
DaVita Clinical Research sites completed over 45,000 research related patient visits in 2018. Our sites have worked with more than 70 sponsors and have learned the pros and cons of… Read more
After a successful and energetic investigator meeting, your highly anticipated clinical trial locomotive is clicking on all cylinders. Enrollment is ahead of schedule, you’re way under budget and ahead of… Read more
Anyone travelling on a long highway after 3 cups of coffee becomes really aware of their kidneys very quickly. But, besides getting rid of excess water, the kidney has other… Read more
Risk Based Monitoring (RBM) is a clinical trial-monitoring method that was developed to fulfil regulatory requirements but moves away from 100% source data verification (SDV) of patient data. RBM, in… Read more
Clinical research provides doctors important information on how to effectively treat patients and is what makes the development of new medicines, procedures, and tools possible. Clinical research allows us… Read more